Abiopharma

🔍 Burns Thomas William (Executive)

Company: GLAUKOS Corp (GKOS)

Report Date: 2026-01-08

Detailed Transactions and Holdings:

• Acquired 88,055 shares of Common Stock at $16.49 per share (Direct)
  Date: 2026-01-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 241,830.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 88,055 shares of Common Stock at $115.0 per share (Direct)
  Date: 2026-01-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 153,775.00 | transaction_form_type: 4 | Footnotes: F2, F1
• Acquired 186,945 shares of Common Stock at $16.49 per share (Direct)
  Date: 2026-01-16 | Code: M | equity_swap_involved: 0 | shares_owned_after: 340,720.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 186,945 shares of Common Stock at $115.0 per share (Direct)
  Date: 2026-01-16 | Code: S | equity_swap_involved: 0 | shares_owned_after: 153,775.00 | transaction_form_type: 4 | Footnotes: F2, F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-08 | Code: H | nature_of_ownership: Through the Burns Family Trust | shares_owned_after: 893,932.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-08 | Code: H | nature_of_ownership: Through the Burns Annuity Trust | shares_owned_after: 238,107.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-08 | Code: H | nature_of_ownership: Through the Burns Charitable Remainder Trust | shares_owned_after: 120,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-08 | Code: H | nature_of_ownership: Through the Thomas W. Burns Irrevocable Trust | shares_owned_after: 100,000.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-01-08 | Code: H | nature_of_ownership: Through the Janet M. Burns Irrevocable Trust | shares_owned_after: 100,000.00
• Sold 88,055 shares of Stock Option (Right to Buy) at $16.49 per share (Derivative)
  Date: 2026-01-08 | Code: M | Expires: 2026-03-10 | equity_swap_involved: 0 | shares_owned_after: 186,945.00 | transaction_form_type: 4 | Footnotes: F3, F4
• Sold 186,945 shares of Stock Option (Right to Buy) at $16.49 per share (Derivative)
  Date: 2026-01-16 | Code: M | Expires: 2026-03-10 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F4

Footnotes:

• F1: Includes 89,621 restricted stock units that have not yet vested or been delivered to the Reporting Person.
• F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2025 with respect to options that expire on March 10, 2026.
• F3: The option exercises in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2025 with respect to options that expire on March 10, 2026.
• F4: This option was granted on March 10, 2016 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date.